Carlo M. Croce, MD
Institute of Genetics, The Ohio State University School of Medicine, Columbus, Ohio
Renowned for his investigations of cancer pathogenesis, Dr. Croce has provided valuable insights into the underlying, genetic basis of cancer onset. His research has established genetic links to a variety of cancers including Burkitt’s lymphoma, T-Cell lymphoma, and acute leukemia. His discoveries have shown that chromosomal abnormalities such as translocations are capable of contributing to both cancer initiation and progression.
In addition to his studies involving genes such as ALL1 and TCL1, Dr. Croce was the first investigator to discover and sequence BCL2. He later defined a role for this protein in various lymphomas such as follicular lymphoma. More recently, Dr. Croce’s work has centered on understanding the role of micro RNAs in cancer pathogenesis. His research has proved that particular micro RNAs have the potential to exhibit either oncogenic or tumor suppressive properties. While heavily involved in research, Dr. Croce also served as editor-in-chief for Cancer Research (1990-1999).
2017 AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research2011 Szent-Györgyi Prize for Progress in Cancer Research2011 Elected Member, Institute of Medicine2010 Elected Fellow, American Academy of Arts and Sciences2006 AACR-G.H.A. Clowes Memorial Award2005 Jeffrey A. Gottlieb Memorial Award, UT MD Anderson Cancer Center2004 John W. Wolfe Chair in Human Cancer Genetics, The Ohio State University2003 President of the Republic Prize, Accademia di Lincei2003 Italian Gold Medal for Public Health2000 Honor of Merit of Italian Republic1999 AACR-Pezcoller International Award for Cancer Research1999 Raymond Bourgine Award and Gold Medal of Paris1996 Elected Member, National Academy of Sciences, Washington, DC1993 Charles S. Mott Prize, General Motors Cancer Research Foundation1990 AACR-Richard and Hinda Rosenthal Foundation Award1969 MD, University of Rome